Related content

A double-blind, placebo-controlled, randomized study to evaluate the efficacy, safety and tolerability of tegaserod in patients with irritable bowel syndrome

By Nyhlin H.   Bang C.   Elsborg L.   Silvennoinen J.   Holme I.   Rüegg P.   Jones J.   Wagner A.  

Scandinavian Journal of Gastroenterology, Vol. 39, Iss. 2, 2004-02 ,pp. : 119-126

Informa Healthcare

Access to resources Recommend Favorite

A 24-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of the Rivastigmine Patch in Japanese Patients with Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders Extra, Vol. 1, Iss. 1, 2011-06 ,pp. : 163-179

Karger

Access to resources Recommend Favorite

Randomized Active and Placebo-Controlled Endoscopy Study of a Novel Protected Formulation of Oral Alendronate

By Marshall John   Thabane Marroon   James Cindy  

Digestive Diseases and Sciences, Vol. 51, Iss. 5, 2006-05 ,pp. : 864-868

Springer Publishing Company

Access to resources Recommend Favorite

Randomized Trial of Alendronate Plus Vitamin D₃ Versus Standard Care in Osteoporotic Postmenopausal Women with Vitamin D Insufficiency

By Ralston Stuart   Binkley Neil   Boonen Steven   Kiel Douglas   Reginster Jean-Yves   Roux Christian   Chen Liang   Rosenberg Elizabeth   Santora Arthur  

Calcified Tissue International, Vol. 88, Iss. 6, 2011-06 ,pp. : 485-494

Springer Publishing Company

Access to resources Recommend Favorite

Oral Administration of 17β-Estradiol Over 3 Months Without Progestin Co-Administration Does Not Improve Coronary Flow Reserve in Post-Menopausal Women: A Randomized Placebo-Controlled Cross-Over CMR Study

By Schwitter Juerg  

Journal of Cardiovascular Magnetic Resonance, Vol. 9, Iss. 4, 2007-07 ,pp. : 665-672

Informa Healthcare

Access to resources Recommend Favorite